» Articles » PMID: 20176674

Early Hyperglycemia is a Risk Factor for Death and White Matter Reduction in Preterm Infants

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2010 Feb 24
PMID 20176674
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to determine whether hyperglycemia during the first week of life in extremely preterm (EPT) infants was associated with increased mortality rates and with cerebral injury, as assessed with MRI of the brain, at term-equivalent age.

Methods: All 143 EPT infants (gestational ages of <27 weeks) who were born at Karolinska University Hospital between January 2004 and December 2006 and were alive at 24 hours were eligible. Of the 118 surviving infants, 24 were excluded for various reasons. MRI was performed for the 94 included survivors at term age, with a 1.5-T system, and scans were scored for gray matter/white matter (WM) abnormalities. Of the 25 infants who died before term age, 6 were excluded because of missing glucose documentation and the remaining 19 were included. Hyperglycemia was defined as plasma glucose levels of >8.3 mmol/L.

Results: Hyperglycemia occurring on the first day of life was identified as an independent risk factor for death (adjusted odds ratio: 3.7 [95% confidence interval: 1.3-10.6]; P = .01). Hyperglycemia occurring on the first day of life also was a risk factor for WM reduction, as determined through MRI, at term-equivalent age (adjusted odds ratio: 3.1 [95% confidence interval: 1.0-9.2]; P = .04).

Conclusion: In this population-based cohort of EPT infants, hyperglycemia on the first day of life was associated with increased mortality rates and brain damage, as reflected by WM reduction at term age.

Citing Articles

Neonatal dysglycemia: a review of dysglycemia in relation to brain health and neurodevelopmental outcomes.

Lagace M, Tam E Pediatr Res. 2024; 96(6):1429-1437.

PMID: 38972961 DOI: 10.1038/s41390-024-03411-0.


Treatment of Severe Hyperglycemia in Extremely Preterm Infants Using Continuous Subcutaneous Insulin Therapy.

Boettger M, Zhou T, Knopp J, Chase J, Heep A, von Vangerow M J Clin Res Pediatr Endocrinol. 2024; 16(4):443-449.

PMID: 38915194 PMC: 11629728. DOI: 10.4274/jcrpe.galenos.2024.2024-2-9.


Insulin resistance prior to term age in very low birthweight infants: a prospective study.

Zamir I, Sjostrom E, van den Berg J, Naumburg E, Domellof M BMJ Paediatr Open. 2024; 8(1).

PMID: 38341196 PMC: 10862284. DOI: 10.1136/bmjpo-2023-002470.


Neonatal hypoglycemia and neurodevelopmental outcomes: Yesterday, today, tomorrow.

De Rose D, Perri A, Maggio L, Salvatori G, Dotta A, Vento G Eur J Pediatr. 2024; 183(3):1113-1119.

PMID: 38180635 DOI: 10.1007/s00431-023-05405-2.


A Higher Amount of Nutritional Intake as a Possible Cause of Hyperglycemia in Extremely Premature Infants in Parenteral and Enteral Nutrition at the Tertiary Neonatal Intensive Care Unit.

Predanic Drobne I, Kornhauser Cerar L, Erculj V, Grosek S Children (Basel). 2023; 10(10).

PMID: 37892314 PMC: 10605466. DOI: 10.3390/children10101651.